Research Summary

Continuous Glucose Monitoring Improves Glycemic Control in Diabetes

Moderate confidence
Low bias
Last updated June 15, 2026

Key Takeaway:

This study examined the impact of continuous glucose monitoring on glycemic control in diabetes patients, finding significant reductions in HbA1c and fasting plasma glucose levels.

Study at a Glance

Participants

Intervention

Continuous glucose monitoring

Outcomes

HbA1c, Fasting blood sugar (FBS), Body mass index (BMI), Total cholesterol

Funding

Non-Industry Sponsored

Save this study and add notes to your research library.

Main Effects

HbA1c decreased from 8.09% to 7.48% (p < 0.001)

Fasting plasma glucose decreased from 152.41 mg/dL to 137.16 mg/dL (p < 0.001)

Total cholesterol decreased from 149.77 mg/dL to 146.95 mg/dL (p = 0.036)

Evidence Summary

InterventionOutcomeMeasured ChangeStudy Effect
Devices & Technology
Continuous glucose monitoring
(Devices & Technology)
Weight & Anthropometrics
BMI
(Weight & Anthropometrics)
No Change
Unclear
Devices & Technology
Continuous glucose monitoring
(Devices & Technology)
Glycemic Control
Fasting blood sugar (FBS)
(Glycemic Control)
Decrease
Strong
Devices & Technology
Continuous glucose monitoring
(Devices & Technology)
Glycemic Control
HbA1c
(Glycemic Control)
Decrease
Strong
Devices & Technology
Continuous glucose monitoring
(Devices & Technology)
Metabolic Health
Total cholesterol
(Metabolic Health)
Decrease
Strong

Unlock Full Evidence Analysis

Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.

evidence suggest

Evidence Suggest

  • HbA1c decreased by 0.61% (p < 0.001).
  • Fasting plasma glucose decreased by 15.25 mg/dL (p < 0.001).
  • Total cholesterol decreased by 2.82 mg/dL (p = 0.036).
who this applies

Who this applies to

  • Adults diagnosed with diabetes mellitus.
  • Patients using continuous glucose monitoring devices.
keep in mind

Keep in Mind

  • Results may not be generalizable to all diabetes populations.
  • The increase in body mass index was not statistically significant.
  • Further research is needed to confirm long-term effects.
between the lines

Between the Lines

  • Study design was non-randomized, limiting causal inference.
  • Sample size and demographic details were not specified.
  • Potential confounding factors were not controlled.

Unlock Full Analysis

Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.

Already have an account?

Journal Reference

Mi-Joon L, Bum-Jeun S, Jae-Hyoung C, Daniela MT, Mariana F, Ionela LS. The Effects of Continuous Glucose Monitoring on Glycemic Control in Patients with Diabetes Mellitus. Life. 2025;15(10):1543. doi:10.3390/life15101543

Connected Evidence

Discover how this study fits into the broader diabetes evidence landscape.

This study contributes to evidence on Continuous Glucose Monitoring and Glycemic Control, Continuous Glucose Monitoring and Glycemic Control.

Related evidence relationships

Explore in Evidence Archive

This study contributes to the evidence on the following intervention–outcome relationships.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.